232 related articles for article (PubMed ID: 10480951)
1. Sulindac inhibits activation of the NF-kappaB pathway.
Yamamoto Y; Yin MJ; Lin KM; Gaynor RB
J Biol Chem; 1999 Sep; 274(38):27307-14. PubMed ID: 10480951
[TBL] [Abstract][Full Text] [Related]
2. Analysis of domains in the IKKalpha and IKKbeta proteins that regulate their kinase activity.
Kwak YT; Guo J; Shen J; Gaynor RB
J Biol Chem; 2000 May; 275(19):14752-9. PubMed ID: 10747982
[TBL] [Abstract][Full Text] [Related]
3. Sulindac activates NF-κB signaling in colon cancer cells.
Mladenova D; Pangon L; Currey N; Ng I; Musgrove EA; Grey ST; Kohonen-Corish MR
Cell Commun Signal; 2013 Oct; 11():73. PubMed ID: 24083678
[TBL] [Abstract][Full Text] [Related]
4. Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappaB activation in HeLa cells occur via a mechanism involving p38 MAP kinase.
Bradbury CM; Markovina S; Wei SJ; Rene LM; Zoberi I; Horikoshi N; Gius D
Cancer Res; 2001 Oct; 61(20):7689-96. PubMed ID: 11606413
[TBL] [Abstract][Full Text] [Related]
5. Sulindac induces apoptotic cell death in susceptible human breast cancer cells through, at least in part, inhibition of IKKbeta.
Seo AM; Hong SW; Shin JS; Park IC; Hong NJ; Kim DJ; Lee WK; Lee WJ; Jin DH; Lee MS
Apoptosis; 2009 Jul; 14(7):913-22. PubMed ID: 19526344
[TBL] [Abstract][Full Text] [Related]
6. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta.
Yin MJ; Yamamoto Y; Gaynor RB
Nature; 1998 Nov; 396(6706):77-80. PubMed ID: 9817203
[TBL] [Abstract][Full Text] [Related]
7. Sulindac suppresses nuclear factor-kappaB activation and RANTES gene and protein expression in endometrial stromal cells from women with endometriosis.
Wieser F; Vigne JL; Ryan I; Hornung D; Djalali S; Taylor RN
J Clin Endocrinol Metab; 2005 Dec; 90(12):6441-7. PubMed ID: 16159934
[TBL] [Abstract][Full Text] [Related]
8. Growth-suppressive effect of non-steroidal anti-inflammatory drugs on 11 colon-cancer cell lines and fluorescence differential display of genes whose expression is influenced by sulindac.
Akashi H; Han HJ; Iizaka M; Nakamura Y
Int J Cancer; 2000 Dec; 88(6):873-80. PubMed ID: 11093808
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of IKK down-regulates antigen + IgE-induced TNF production by mast cells: a role for the IKK-IkappaB-NF-kappaB pathway in IgE-dependent mast cell activation.
Peng Y; Power MR; Li B; Lin TJ
J Leukoc Biol; 2005 Jun; 77(6):975-83. PubMed ID: 15784689
[TBL] [Abstract][Full Text] [Related]
10. Cell stress and MKK6b-mediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IkappaB phosphorylation and NF-kappaB activation.
Alpert D; Schwenger P; Han J; Vilcek J
J Biol Chem; 1999 Aug; 274(32):22176-83. PubMed ID: 10428782
[TBL] [Abstract][Full Text] [Related]
11. Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs.
Li X; Gao L; Cui Q; Gary BD; Dyess DL; Taylor W; Shevde LA; Samant RS; Dean-Colomb W; Piazza GA; Xi Y
Oncogene; 2012 Nov; 31(48):4979-86. PubMed ID: 22286762
[TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation.
Takada Y; Bhardwaj A; Potdar P; Aggarwal BB
Oncogene; 2004 Dec; 23(57):9247-58. PubMed ID: 15489888
[TBL] [Abstract][Full Text] [Related]
13. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
14. Sulindac enhances tumor necrosis factor-alpha-mediated apoptosis of lung cancer cell lines by inhibition of nuclear factor-kappaB.
Berman KS; Verma UN; Harburg G; Minna JD; Cobb MH; Gaynor RB
Clin Cancer Res; 2002 Feb; 8(2):354-60. PubMed ID: 11839649
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.
Rice PL; Goldberg RJ; Ray EC; Driggers LJ; Ahnen DJ
Cancer Res; 2001 Feb; 61(4):1541-7. PubMed ID: 11245463
[TBL] [Abstract][Full Text] [Related]
16. ROCK and nuclear factor-kappaB-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences.
Benitah SA; Valerón PF; Lacal JC
Mol Biol Cell; 2003 Jul; 14(7):3041-54. PubMed ID: 12857884
[TBL] [Abstract][Full Text] [Related]
17. Sulindac, a nonsteroidal anti-inflammatory drug, selectively inhibits interferon-gamma-induced expression of the chemokine CXCL9 gene in mouse macrophages.
Sakaeda Y; Hiroi M; Shimojima T; Iguchi M; Kanegae H; Ohmori Y
Biochem Biophys Res Commun; 2006 Nov; 350(2):339-44. PubMed ID: 17010317
[TBL] [Abstract][Full Text] [Related]
18. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.
Piazza GA; Rahm AL; Krutzsch M; Sperl G; Paranka NS; Gross PH; Brendel K; Burt RW; Alberts DS; Pamukcu R
Cancer Res; 1995 Jul; 55(14):3110-6. PubMed ID: 7606732
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex.
May MJ; D'Acquisto F; Madge LA; Glöckner J; Pober JS; Ghosh S
Science; 2000 Sep; 289(5484):1550-4. PubMed ID: 10968790
[TBL] [Abstract][Full Text] [Related]
20. Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells.
Yip-Schneider MT; Nakshatri H; Sweeney CJ; Marshall MS; Wiebke EA; Schmidt CM
Mol Cancer Ther; 2005 Apr; 4(4):587-94. PubMed ID: 15827332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
